Transformation of human B-lympocytes with Epstein Barr virus and

Chemistry: molecular biology and microbiology – Spore forming or isolating process

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530387, 530809, 530808, 530828, 435 7021, 435 696, 4351722, 4351723, 43524021, 4352402, 43524026, 4353201, 935 32, 935 34, 935 57, 935 71, 935 93, 935100, 935108, 935109, C07K 1528, C12N 522, C12N 524, C12N 1585

Patent

active

049977644

ABSTRACT:
Disclosed herein is a method for transforming human B-cells by infecting them with Epstein Barr virus and transfecting the Epstein Barr virus infected cells with an activated human c-myc gene. The transformed cells are useful for producing human monoclonal antibodies.

REFERENCES:
patent: 4701409 (1987-12-01), Croce
patent: 4740461 (1988-04-01), Kaufman
Lombardi et al., Cell, 49, 161-170, Apr. 24, 1987.
Kessler et al., Canc. Res., 47, 527-531, (Jan. 1987).
Dalla Favera et al., NYAS, vol. 511, "Normal and Neoplastic Blood Cells; From Genes to Therapy", Disclosed Jun. 10-13, 1986 (Rome, Italy) published 1987, New York.
Wennborg et al., Int. J. Cancer, 40, 202-206, (1987).
Polack et al., Embo. J., 6(10), 2959-2964, 1987.
Van Meel et al., J. Immunol. Meth., 80, 267-276, (1985).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Transformation of human B-lympocytes with Epstein Barr virus and does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transformation of human B-lympocytes with Epstein Barr virus and, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transformation of human B-lympocytes with Epstein Barr virus and will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-496261

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.